Accuray Inc (ARAY) Company Profile & Statistics

Accuray Inc
ARAY
(Nasdaq - US)
Open
1.94
+0.05 (+2.65%)
in:usd•As of: Nov 22, 2024 14:48 UTC -5
Open
1.89
High
1.95
Low
1.88

About Accuray Inc

CEO

Suzanne Winter

Headquarters

1240 deming way

madison, wi 53717, united states

Auditor

GRANT THORNTON LLP

Employees

987

Share Holders

165

Website

www.accuray.com

Industry

medical specialties

Sector

health technology

Company Overview

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.

Accuray Inc Statistics

Valuation Measures

Market Capitalization ²	195.11M
Enterprise Value	305.65M
Enterprise Value/EBITDA (ttm)	94.60
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.08
Price to Sales (ttm)	0.42
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	31.20%
Operating Margin (ttm)	-3.72%
Profit Margin (ttm)	-4.15%
Return on Equity (ttm)	-36.93%
Return on Invested Capital (ttm)	-7.81%
Return on Assets (ttm)	-3.52%

Income Statement

Revenue (ttm)	444.20M
Revenue Per Share (ttm)	4.42
Gross Profit (ttm)	137.90M
EBITDA (ttm)³	3.23M
Net Income Avi to Common (ttm)	-16.53M
Diluted EPS (ttm)	-0.17

Share Statistics

Beta (5Y Monthly)	1.40
52-Week Change	-28.41%
S&P500 52-Week Change	30.90%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	100.56M
Dividend Yield	0.00%
Float ⁴	96.31M
% Held by Insiders	4.23%
% Held by Institutions	64.08%

Balance Sheet

Total Cash (mrq)	59.69M
Total Cash Per Share (mrq)	0.59
Total Debt (mrq)	170.24M
Total Debt/Equity (mrq)	376.45%
Current Ratio (mrq)	1.63%
Quick Ratio (mrq)	0.87%
Book Value Per Share (mrq)	0.45

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.07
Free Cash Flow (ytd)	-8.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Accuray Inc

Trade With A Regulated Broker